Read more
"The papers included in two volumes of Annals of the New York Academy of Sciences provide a cross-section of the information presented at the 5th 'Advances Against Aspergillosis'"--Page viii.
List of contents
Preface for Advances against aspergillosis / Karl V. Clemons, David S. Perlin, and Malcolm Richardson Evolution of modular conidiophore development in the aspergilli / Steven D. Harris
Aspergillus flavus diversity on crops and in the environment can be exploited to reduce aflatoxin exposure and improve health / Hillary L. Mehl [and others]
Current section and species complex concepts in Aspergillus : recommendations for routine daily practice / Ana Alastruey-Izquierdo, Emilia Mellado, and Manuel Cuenca-Estrella
The diverse applications of RNA-seq for functional genomic studies in Aspergillus fumigatus / Antonis Rokas [and others]
Conservation in Aspergillus fumigatus of pH-signaling seven transmembrane domain and arrestin proteins, and implications for drug discovery / Elaine M. Bignell
Protein targets for broad-spectrum mycosis vaccines : quantitative proteomic analysis of Aspergillus and Coccidioides and comparisons with other fungal pathogens / Jackson Champer [and others]
Inflammation in aspergillosis : the good, the bad, and the therapeutic / Agostinho Carvalho [and others]
Pattern recognition receptors and their role in invasive aspergillosis / Mark S. Gresnigt, Mihai G. Netea, and Frank L. van de Veerdonk
Activation of the neutrophil NADPH oxidase by Aspergillus fumigatus / Keith B. Boyle, Len R. Stephens, and Phillip T. Hawkins
The top three areas of basic research on Aspergillus fumigatus in 2011 / Nir Osherov
The cell biology of the innate immune response to Aspergillus fumigatus / Michael K. Mansour, Jenny M. Tam, and Jatin M. Vyas
About the author
Karl V Clemons, Stanford University, Stanford, California.
Malcolm Richardson, University of Manchester, Manchester, United Kingdom.
David S Perlin, UMDNJ-New Jersey Medical School, Newark, New Jersey.
Summary
Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance.
